Analgesics in Spain

Analgesics in Spain
Since 2020, a factor supporting the growth of analgesics was the increased tendency of doctors to prescribe acetaminophen, among other common types of analgesics, as a way of managing the symptoms of patients with COVID-19, including muscle and joint pains, fever, headaches and sinus inflammation. While growth of adult acetaminophen in 2021 and 2022 remained dynamic, retail volume sales in 2023 are starting to decline in line with the end of pandemic-related measures (the wearing of face masks,...

Euromonitor International's Analgesics in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.